일일 필수 논문 모음집에 오신 것을 환영합니다. 이 책은 구성된 주제를 기반으로 PubMed에서 최신 필수 논문을 자동으로 수집하여 매일 업데이트됩니다.
이 시스템은 PubMed에서 논문을 검색하고, 인용 수, 임팩트 팩터, 최신성을 기준으로 점수를 매겨 상위 논문을 이곳에 소개합니다.
날짜 주제 제목 저널 점수 링크
2026-01-26 Ai-Drug-Discovery AI-driven drug discovery and repurposing using multi-omics for myocardial infarction and heart failure. Exploration of medicine 60.7 PMID , DOI 2026-01-26 Ai-Drug-Discovery Explainable artificial intelligence for molecular design in pharmaceutical research. Chemical science 59.7 PMID , DOI 2026-01-26 Ai-Drug-Discovery Artificial Intelligence and Machine Learning in Antimicrobial Discovery, Resistance Prediction, and Precision Therapy. International journal of antimicrobial agents 58.1 PMID , DOI 2026-01-26 De-Novo-Protein-Design Data-driven de novo design of super-adhesive hydrogels. Nature 74.5 PMID , DOI 2026-01-26 De-Novo-Protein-Design Integrated biotechnological and AI innovations for crop improvement. Nature 71.2 PMID , DOI 2026-01-26 De-Novo-Protein-Design Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation. International journal of pharmaceutics 70.0 PMID , DOI 2026-01-27 Ai-Drug-Discovery Artificial intelligence in human immunodeficiency virus mutation prediction and drug design: Advancing personalized treatment and prevention. Pharmaceutical science advances 59.0 PMID , DOI 2026-01-31 Ai-Drug-Discovery Machine learning for drug-target interaction prediction: A comprehensive review of models, challenges, and computational strategies. Computational and structural biotechnology journal 58.5 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-02-13 Biomedical Research CRISPR-Cas9 gene editing: A revolutionary tool for precision medicine Nature 95.8 PMID , DOI 2026-02-13 Biomedical Research Machine learning approaches for drug discovery and development Nature Biotechnology 92.3 PMID , DOI 2026-02-13 Biomedical Research COVID-19 vaccine efficacy and safety in real-world populations New England Journal of Medicine 98.1 PMID , DOI 2026-02-01 Ai-Drug-Discovery Explainable artificial intelligence for molecular design in pharmaceutical research. Chemical science 59.7 PMID , DOI 2026-02-01 Ai-Drug-Discovery Artificial intelligence in human immunodeficiency virus mutation prediction and drug design: Advancing personalized treatment and prevention. Pharmaceutical science advances 59.0 PMID , DOI 2026-02-01 Ai-Drug-Discovery Machine learning for drug-target interaction prediction: A comprehensive review of models, challenges, and computational strategies. Computational and structural biotechnology journal 58.5 PMID , DOI 2026-02-01 De-Novo-Protein-Design Data-driven de novo design of super-adhesive hydrogels. Nature 75.3 PMID , DOI 2026-02-01 De-Novo-Protein-Design Integrated biotechnological and AI innovations for crop improvement. Nature 71.3 PMID , DOI 2026-02-01 De-Novo-Protein-Design Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation. International journal of pharmaceutics 70.8 PMID , DOI 2026-02-03 Ai-Drug-Discovery Artificial Intelligence to Guide Repurposing of Drugs. Annual review of medicine 57.9 PMID , DOI 2026-02-06 Ai-Drug-Discovery Beyond the chain of survival: a scoping review of artificial intelligence applications in cardiac arrest. World journal of emergency medicine 56.1 PMID , DOI 2026-02-11 Ai-Drug-Discovery Peptide Arrays as Tools for Unraveling Tumor Microenvironments and Drug Discovery in Oncology. Cells 55.5 PMID , DOI 2026-02-14 ai-drug-discovery Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence. International journal of molecular sciences 56.4 PMID , DOI 2026-02-14 ai-drug-discovery Mining the Hidden Pharmacopeia: Fungal Endophytes, Natural Products, and the Rise of AI-Driven Drug Discovery. International journal of molecular sciences 56.3 PMID , DOI 2026-02-15 ai-drug-discovery Kinic index: an artificial intelligence-driven predictive model and multitarget drug discovery framework for hepatocellular carcinoma patients. NPJ precision oncology 60.0 PMID , DOI 2026-02-16 de-novo-protein-design Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. Nature chemical biology 68.2 PMID , DOI 2026-02-20 ai-drug-discovery Next-Generation Artificial Intelligence for ADME Prediction in Drug Discovery: From Small Molecules to Biologics. Yonago acta medica 60.0 PMID , DOI 2026-02-27 ai-drug-discovery Human in the loop artificial intelligence in healthcare: applications, outcomes, and implementation challenges. International journal of medical informatics 56.4 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-03-05 ai-drug-discovery Next-Generation Artificial Intelligence for ADME Prediction in Drug Discovery: From Small Molecules to Biologics. Yonago acta medica 59.8 PMID , DOI 2026-03-05 ai-drug-discovery Kinic index: an artificial intelligence-driven predictive model and multitarget drug discovery framework for hepatocellular carcinoma patients. NPJ precision oncology 59.8 PMID , DOI 2026-03-05 ai-drug-discovery Human in the loop artificial intelligence in healthcare: applications, outcomes, and implementation challenges. International journal of medical informatics 56.4 PMID , DOI 2026-03-05 de-novo-protein-design Data-driven de novo design of super-adhesive hydrogels. Nature 76.0 PMID , DOI 2026-03-05 de-novo-protein-design Integrated biotechnological and AI innovations for crop improvement. Nature 72.4 PMID , DOI 2026-03-05 de-novo-protein-design Accurate de novo design of high-affinity protein-binding macrocycles using deep learning. Nature chemical biology 69.0 PMID , DOI 2026-03-07 ai-drug-discovery Sustainable Strategies in Tuberculosis Management: Bridging Ethnobotanical Pharmacology, Advanced Drug Delivery, and AI-Driven Innovation. Journal of evidence-based medicine 54.7 PMID , DOI 2026-03-10 ai-drug-discovery Harnessing AI to decode protein kinases: Structural, functional, and therapeutic design perspectives. New biotechnology 52.9 PMID , DOI 2026-03-10 de-novo-protein-design Semantic design of functional de novo genes from a genomic language model. Nature 68.1 PMID , DOI 2026-03-11 ai-drug-discovery Overview of recent strategic advances in antiviral covalent inhibitors. Future medicinal chemistry 53.0 PMID , DOI 2026-03-11 de-novo-protein-design Computational design of metallohydrolases. Nature 68.2 PMID , DOI 2026-03-14 ai-drug-discovery Re-defining the 3Rs of pre-clinical research in nuclear medicine. Seminars in nuclear medicine 53.0 PMID , DOI 2026-03-15 ai-drug-discovery Artificial Intelligence-Driven Natural Product Discovery for Cancer Metastasis and Chemoresistance: From Computational Prediction to Preclinical Validation. Cancers 58.1 PMID , DOI 2026-03-17 ai-drug-discovery Drug repurposing in oncology: Bridging computational discovery to clinical application. International journal of cancer 56.5 PMID , DOI 2026-03-19 ai-drug-discovery Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review. Renal failure 54.6 PMID , DOI 2026-03-26 ai-drug-discovery OptiSyn: an interpretable, multi-omics-driven graph convolutional network framework for synergy-oriented drug combination design in disease treatment. Chinese medicine 54.7 PMID , DOI 2026-03-29 de-novo-protein-design Computational enzyme design by catalytic motif scaffolding. Nature 65.9 PMID , DOI 2026-03-31 de-novo-protein-design De novo design of light-responsive protein-protein interactions enables reversible formation of protein assemblies. Nature chemistry 63.3 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-04-01 ai-drug-discovery Artificial Intelligence-Driven Natural Product Discovery for Cancer Metastasis and Chemoresistance: From Computational Prediction to Preclinical Validation. Cancers 57.9 PMID , DOI 2026-04-01 ai-drug-discovery Drug repurposing in oncology: Bridging computational discovery to clinical application. International journal of cancer 56.3 PMID , DOI 2026-04-01 ai-drug-discovery OptiSyn: an interpretable, multi-omics-driven graph convolutional network framework for synergy-oriented drug combination design in disease treatment. Chinese medicine 54.7 PMID , DOI 2026-04-01 de-novo-protein-design Semantic design of functional de novo genes from a genomic language model. Nature 69.1 PMID , DOI 2026-04-01 de-novo-protein-design Computational design of metallohydrolases. Nature 68.0 PMID , DOI 2026-04-01 de-novo-protein-design Computational enzyme design by catalytic motif scaffolding. Nature 65.9 PMID , DOI 2026-04-02 ai-drug-discovery Towards intelligent and miniaturized drug delivery devices. Nature 57.9 PMID , DOI 2026-04-06 ai-drug-discovery Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review. Renal failure 54.5 PMID , DOI 2026-04-07 ai-drug-discovery Deep-learning-based de novo discovery and design of therapeutics that reverse disease-associated transcriptional phenotypes. Cell 53.0 PMID , DOI 2026-04-08 ai-drug-discovery An international mega-analysis of psychedelic drug effects on brain circuit function. Nature medicine 56.5 PMID , DOI 2026-04-15 ai-drug-discovery A Comparative Review of Artificial Intelligence Applications in Small Molecule Versus Peptide Drug Discovery. International journal of molecular sciences 59.8 PMID , DOI 2026-04-16 ai-drug-discovery Stem Cell-Derived Organoids for Cancer Therapy: Precision Medicine and Drug Selection. International journal of molecular sciences 54.5 PMID , DOI 2026-04-18 ai-drug-discovery A review on AI-enabled drug design in medicinal chemistry: Analytical validation, challenges, and regulatory considerations. Talanta 54.7 PMID , DOI 2026-04-24 ai-drug-discovery AI/ML in drug product development & manufacturing - report on the 8th APV Winter conference. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 54.7 PMID , DOI 2026-04-25 ai-drug-discovery Artificial intelligence driven innovation in tuberculosis drug discovery. The Indian journal of tuberculosis 59.8 PMID , DOI 2026-04-28 ai-drug-discovery From Prompt to Drug: Toward Pharmaceutical Superintelligence. ACS central science 58.7 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-05-01 ai-drug-discovery Artificial intelligence driven innovation in tuberculosis drug discovery. The Indian journal of tuberculosis 59.8 PMID , DOI 2026-05-01 ai-drug-discovery Artificial intelligence-assisted neuropharmacology: reshaping drug discovery and translational strategies for neurological diseases. Turkish journal of medical sciences 58.9 PMID , DOI 2026-05-01 ai-drug-discovery From Prompt to Drug: Toward Pharmaceutical Superintelligence. ACS central science 58.7 PMID , DOI 2026-05-01 de-novo-protein-design Computational design of metallohydrolases. Nature 69.5 PMID , DOI 2026-05-01 de-novo-protein-design Semantic design of functional de novo genes from a genomic language model. Nature 68.8 PMID , DOI 2026-05-01 de-novo-protein-design Computational enzyme design by catalytic motif scaffolding. Nature 66.7 PMID , DOI 2026-05-12 ai-drug-discovery AI and network biology for rational polypharmacology in signaling drug design: a review. NPJ precision oncology 54.7 PMID , DOI 2026-05-14 ai-drug-discovery Next-Generation Artificial Intelligence Strategies for Mechanistic Cancer Target Discovery and Drug Development: A State-of-the-Art Review. International journal of molecular sciences 59.9 PMID , DOI 2026-05-14 ai-drug-discovery Artificial Intelligence Tools in Precision Lung Cancer Care: From Early Detection to Clinical Decision Support. Cancers 56.4 PMID , DOI 2026-05-20 ai-drug-discovery Emerging Innovations in Current Drug Discovery Technologies: The Role of Regulatory Policies and Financial Investments in Healthcare Transformation. Current drug discovery technologies 56.4 PMID , DOI 2026-05-20 ai-drug-discovery Pharmaceutical Industry 5.0: The Role of Drug Discovery Technology, Innovation, and Digital Transformation in Economic Resilience. Current drug discovery technologies 56.4 PMID , DOI 2026-05-21 de-novo-protein-design Atom-level enzyme active site scaffolding using RFdiffusion2. Nature methods 64.9 PMID , DOI 2026-05-28 ai-drug-discovery A Risk-Tiered Validation Framework for Artificial Intelligence in Drug Discovery: From Reproducibility to Clinical Translation. International journal of molecular sciences 59.9 PMID , DOI 2026-05-30 ai-drug-discovery From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of medical Internet research 56.5 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-06-01 ai-drug-discovery A Risk-Tiered Validation Framework for Artificial Intelligence in Drug Discovery: From Reproducibility to Clinical Translation. International journal of molecular sciences 59.8 PMID , DOI 2026-06-01 ai-drug-discovery From Virtual Molecules to Clinical Trials: How AI Is Reshaping Preclinical Drug Discovery. Journal of medical Internet research 56.5 PMID , DOI 2026-06-01 ai-drug-discovery Harnessing artificial intelligence for pediatric health: Current trends and future opportunities. iScience 56.2 PMID , DOI 2026-06-01 de-novo-protein-design Computational design of metallohydrolases. Nature 70.6 PMID , DOI 2026-06-01 de-novo-protein-design Computational enzyme design by catalytic motif scaffolding. Nature 68.2 PMID , DOI 2026-06-01 de-novo-protein-design Atom-level enzyme active site scaffolding using RFdiffusion2. Nature methods 64.8 PMID , DOI 2026-06-05 ai-drug-discovery Integrating artificial intelligence into drug delivery systems: Formulation development and current challenges. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 58.2 PMID , DOI 2026-06-06 de-novo-protein-design The past, present and future of de novo protein design. Nature 67.6 PMID , DOI 2026-06-12 ai-drug-discovery Artificial Intelligence in Tumor Evolution: Understanding Cancer Complexity Through Multi-Modal Data Integration in Precision Oncology. Cells 56.4 PMID , DOI 2026-06-13 de-novo-protein-design From traditional to AI-driven: The evolution of intelligent enzyme engineering for biocatalysis. Biotechnology advances 61.6 PMID , DOI 2026-06-16 ai-drug-discovery Integration of Federated Learning and Blockchain in Health Care: Tutorial on Medical Data, Architectures, Privacy, Security, and Regulatory Compliance. Journal of medical Internet research 57.0 PMID , DOI 2026-06-16 ai-drug-discovery Advancing Drug Discovery with AI: Machine and Deep Learning Strategies for Target Identification and Precision Nanomedicine. International journal of nanomedicine 56.4 PMID , DOI 2026-06-17 ai-drug-discovery Artificial intelligence in drug discovery. Nature biotechnology 56.8 PMID , DOI 2026-06-17 de-novo-protein-design Unified modeling of 3D molecular generation via atomic interactions with PocketXMol. Cell 61.2 PMID , DOI 2026-06-25 ai-drug-discovery Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform. Nature protocols 58.9 PMID , DOI 2026-06-27 de-novo-protein-design De novo design of small molecule-regulated protein oligomers. Science (New York, N.Y.) 61.8 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-07-01 ai-drug-discovery Facilitating structure-based drug discovery with an artificial intelligence-driven virtual screening platform. Nature protocols 58.8 PMID , DOI 2026-07-01 ai-drug-discovery Artificial intelligence in drug discovery. Nature biotechnology 56.7 PMID , DOI 2026-07-01 ai-drug-discovery Artificial intelligence empowers the innovation of traditional Chinese medicine. Journal of integrative medicine 56.5 PMID , DOI 2026-07-01 de-novo-protein-design The past, present and future of de novo protein design. Nature 70.4 PMID , DOI 2026-07-01 de-novo-protein-design De novo design of small molecule-regulated protein oligomers. Science (New York, N.Y.) 61.8 PMID , DOI 2026-07-01 de-novo-protein-design Unified modeling of 3D molecular generation via atomic interactions with PocketXMol. Cell 61.1 PMID , DOI 2026-07-02 ai-drug-discovery From Molecules to Manufacturing: Expanding Role of Artificial Intelligence in Pharmaceutical Sciences. Current drug discovery technologies 56.5 PMID , DOI 2026-07-08 ai-drug-discovery Artificial intelligence in respiratory medicine: From diagnosis to treatment and future directions. Chinese medical journal pulmonary and critical care medicine 56.2 PMID , DOI 2026-07-09 de-novo-protein-design AI accelerate the identification of druggable targets by 3D structures of proteins and compounds. NPJ precision oncology 60.8 PMID , DOI 2026-07-12 ai-drug-discovery Autonomous biomedical research with an artificial intelligence agent. Science (New York, N.Y.) 55.3 PMID , DOI 2026-07-16 ai-drug-discovery Evaluating AI-Generated Molecules for Drug Discovery: From Generic Metrics to Translational Readiness. International journal of molecular sciences 56.3 PMID , DOI 2026-07-16 ai-drug-discovery Integrated Screening Cascades for Ion-Channel Drug Discovery: Linking Structure, Electrophysiology, Safety Pharmacology, and Human-Relevant Models. International journal of molecular sciences 56.3 PMID , DOI 2026-07-22 de-novo-protein-design Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging Paradigms. Computational and structural biotechnology journal 58.3 PMID , DOI 2026-07-23 de-novo-protein-design Deep learning revolutionizes protein research: Advances in structure prediction, functional annotation, and engineered design. Journal of biotechnology 58.2 PMID , DOI 2026-07-24 ai-drug-discovery Innovative strategies for anti-fibrotic drugs discovery from traditional Chinese medicine. Chinese herbal medicines 57.9 PMID , DOI 2026-07-25 de-novo-protein-design Evaluating generalization in protein-ligand cofolding methods. Nature structural & molecular biology 59.3 PMID , DOI 2026-07-28 de-novo-protein-design Bioinformatic and computational biophysics tools for nanopore engineering: a review from standard approaches to machine learning advancements. Journal of nanobiotechnology 59.4 PMID , DOI 2026-07-30 ai-drug-discovery Conditional superiorities and unaddressed bottlenecks: a critical review of artificial intelligence for waterborne microbial detection. Applied microbiology and biotechnology 54.9 PMID , DOI 2026-07-30 ai-drug-discovery AI-driven discovery of multifunctional peptides: From sequence space to therapeutics. Biotechnology advances 54.7 PMID , DOI
날짜 주제 제목 저널 점수 링크
2026-08-01 ai-drug-discovery Innovative strategies for anti-fibrotic drugs discovery from traditional Chinese medicine. Chinese herbal medicines 57.8 PMID , DOI 2026-08-01 ai-drug-discovery Conditional superiorities and unaddressed bottlenecks: a critical review of artificial intelligence for waterborne microbial detection. Applied microbiology and biotechnology 54.9 PMID , DOI 2026-08-01 ai-drug-discovery AI-driven discovery of multifunctional peptides: From sequence space to therapeutics. Biotechnology advances 54.7 PMID , DOI 2026-08-01 de-novo-protein-design The past, present and future of de novo protein design. Nature 73.9 PMID , DOI 2026-08-01 de-novo-protein-design Evaluating generalization in protein-ligand cofolding methods. Nature structural & molecular biology 59.9 PMID , DOI 2026-08-01 de-novo-protein-design Bioinformatic and computational biophysics tools for nanopore engineering: a review from standard approaches to machine learning advancements. Journal of nanobiotechnology 59.3 PMID , DOI 2026-08-05 ai-drug-discovery Deep Learning-Based Virtual Screening Identifies Potential Small-Molecule Inhibitors of ASK1: Natural Product Lead Discovery for MASH. International journal of molecular sciences 54.6 PMID , DOI 2026-08-05 de-novo-protein-design FLOWR: flow matching for structure-aware de novo, interaction- and fragment-based ligand generation. Nature computational science 58.7 PMID , DOI 2026-08-07 ai-drug-discovery Multi-organ AI endophenotypes chart the heterogeneity of brain, eye and heart pan-disease. Nature. Mental health 55.8 PMID , DOI 2026-08-08 ai-drug-discovery Artificial intelligence in drug discovery - what it is, where we stand and the path forward. Nature reviews. Drug discovery 54.8 PMID , DOI 2026-08-09 ai-drug-discovery Artificial intelligence catalyzes antimicrobial peptide design. Synthetic and systems biotechnology 56.4 PMID , DOI 2026-08-12 ai-drug-discovery Drug Discovery's Blind Spot: Why Organoid-Artificial Intelligence Convergence Demands Integrated Governance. The American journal of bioethics : AJOB 60.0 PMID , DOI 2026-08-12 ai-drug-discovery Hangzhou declaration on the global development of artificial intelligence in traditional Chinese medicine. Journal of integrative medicine 56.3 PMID , DOI 2026-08-13 Biomedical Research CRISPR-Cas9 gene editing: A revolutionary tool for precision medicine Nature 95.8 PMID , DOI 2026-08-13 Biomedical Research Machine learning approaches for drug discovery and development Nature Biotechnology 92.3 PMID , DOI 2026-08-13 Biomedical Research COVID-19 vaccine efficacy and safety in real-world populations New England Journal of Medicine 98.1 PMID , DOI 2026-08-15 ai-drug-discovery Advancing cancer drug discovery through the integration of machine learning and high-throughput screening. Future medicinal chemistry 38.5 PMID , DOI 2026-08-15 de-novo-protein-design Protein Design Enters the Artificial Intelligence Era: Foundations, Tools, and Emerging Paradigms. Computational and structural biotechnology journal 40.8 PMID , DOI 2026-08-15 de-novo-protein-design Decoding bacterial transcriptional regulatory networks through integrated multi-omics datasets for artificial intelligence-driven design of programmable biological systems. Current opinion in biotechnology 38.7 PMID , DOI